我和丰满岳疯狂做爰,久久久久亚洲AV片无码,亚洲色欲一区二区三区在线观看,疯狂做受XXXX高潮欧美日本

掃碼關注公眾號           掃碼咨詢技術支持           掃碼咨詢技術服務
  
客服熱線:400-901-9800  客服QQ:4009019800  技術答疑  技術支持  質量反饋  關于我們  聯系我們
久久99精品久久久久久噜噜,国产精品一区二区AV,精品无码国产一区二区三区AV
首頁 > 產品中心 > 一抗 > 產品信息
CD80 Rabbit pAb (bs-2211R)  
訂購熱線:400-901-9800
訂購郵箱:sales@www.ssxsbs.com
訂購QQ:  400-901-9800
技術支持:techsupport@www.ssxsbs.com
50ul/1180.00元
100ul/1980.00元
200ul/2800.00元
大包裝/詢價

產品編號 bs-2211R
英文名稱 CD80 Rabbit pAb
中文名稱 刺激分子B7-1蛋白抗體
別    名 Activation B7-1 antigen; B lymphocyte activation antigen B7; B7; B7-1; B7-1 antigen; BB1; CD28 antigen ligand 1; CD28LG; CD28LG1; CD80; CD80 antigen(CD28 antigen ligand 1, B7-1 antigen); CD80 antigen; CD80 molecule; CD80_HUMAN; Costimulatory factor CD80; costimulatory molecule variant IgV-CD80; CTLA-4 counter-receptor B7.1; LAB7; T-lymphocyte activation antigen CD80; CD80_RAT.  
Specific References  (27)     |     bs-2211R has been referenced in 27 publications.
[IF=17.521] Yanlun Zhu. et al. Oral Delivery of Bioactive Glass-Loaded Core–Shell Hydrogel Microspheres for Effective Treatment of Inflammatory Bowel Disease. Advanced Science. 2023 Apr;:2207418  IHC ;  Mouse.  
[IF=10.761] Gaolong Lin. et al. Polydopamine-cladded montmorillonite micro-sheets as therapeutic platform repair the gut mucosal barrier of murine colitis through inhibiting oxidative stress. MATER TODAY BIO. 2023 Jun;20:100654  IF ;  Mouse.  
[IF=10.652] Lifen Wang. et al. Thermo-sensitive hydrogel with mussel-inspired adhesion enhanced the non-fibrotic repair effect of EGF on colonic mucosa barrier of TNBS-induced ulcerative colitis rats through macrophage polarizing. Chem Eng J. 2021 Jul;416:129221  IF ;  Rat.  
[IF=10.435] Xu, Hua-Zhen. et al. Synergy of nanodiamond–doxorubicin conjugates and PD-L1 blockade effectively turns tumor-associated macrophages against tumor cells. J Nanobiotechnol. 2021 Dec;19(1):1-24  IHC ;  mouse.  
[IF=8.806] Li TF et al. Dendritic cell-mediated delivery of doxorubicin-polyglycerol-nanodiamond composites elicits enhanced anti-cancer immune response in glioblastoma.Biomaterials. 2018 Oct;181:35-52.  IHC-P ;  Human.  
[IF=7.727] Jinbo Li. et al. Low dose shikonin and anthracyclines coloaded liposomes induce robust immunogenetic cell death for synergistic chemo-immunotherapy. J Control Release. 2021 Jul;335:306  IHC ;  Mouse.  
[IF=7.182] Chengxiao Wang. et al. Dissolvable microneedles based on Panax notoginseng polysaccharide for transdermal drug delivery and skin dendritic cell activation. Carbohyd Polym. 2021 May;:118211  IHC ;  Mouse.  
[IF=6.27] Bai J et al. Reactive Oxygen Species‐Scavenging Scaffold with Rapamycin for Treatment of Intervertebral Disk Degeneration. Adv Healthc Mater. 2019 Dec 10:e1901186.  IHC-P,IHF-P&WB ;  Rat&Mouse.  
[IF=6.1] Xing Chang. et al. Targeting HMGA1 contributes to immunotherapy in aggressive breast cancer while suppressing EMT. BIOCHEM PHARMACOL. 2023 May;:115582  IHC ;  Human.  
[IF=6.081] Xuan Wang. et al. Probiotic Bifidobacterium bifidum G9-1 Has a Preventive Effect on the Acceleration of Colonic Permeability and M1 Macrophage Population in Maternally Separated Rats. Biomedicines. 2021 Jun;9(6):641  IHC ;  Rat.  
[IF=5.345] Yuan SJ et al. Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer.J Nanobiotechnology. 2019 Oct 17;17(1):110.  IHC-P ;  Mouse.  
[IF=5.215] Tianrui Zhang. et al. Daphnetin Improves Neuropathic Pain by Inhibiting the Expression of Chemokines and Inflammatory Factors in the Spinal Cord and Interfering with Glial Cell Polarization. PHARMACEUTICALS-BASE. 2023 Feb;16(2):243  IF ;  Rat.  
[IF=5.19] Han, Sheng, et al. "LPS alters the immuno-phenotype of glioma and glioma stem-like cells and induces in vivo antitumor immunity via TLR4." Journal of Experimental & Clinical Cancer Research 36.1 (2017): 83.  WB ;  Human.  
[IF=4.854] Linghao Xiao. et al. Osteogenic capacity of octacalcium phosphate involving macrophage polarization. J BIOMED MATER RES A. 2022 Dec;:  IHC ;  Rat.  
[IF=3.701] Keiichi Hiramoto. et al. Innate immune activation and antitumor effects of Lactobacillus-fermented Sparassis crispa extract in mice. J Funct Foods. 2020 Dec;75:104215  IHC ;  Mouse.  
[IF=3.616] Moser PT et al. Creation of Laryngeal Grafts from Primary Human Cells and Decellularized Laryngeal Scaffolds. Tissue Eng Part A. 2019 Oct 30.  IHC-P ;  
[IF=3.496] Philipp T Moser et al. Creation of Laryngeal Grafts from Primary Human Cells and Decellularized Laryngeal Scaffolds. Tissue Eng Part A. 2020 May;26(9-10):543-555.  IF ;  Rat.  
[IF=3.251] Masataka Kadowaki. et al. Involvement of M1/M2 Macrophage Polarization in Reparative Dentin Formation. LIFE-BASEL. 2022 Nov;12(11):1812  IF ;  Human.  
[IF=3.118] Yu S et al. Dendritic cells modified with Der p1 antigen as a therapeutic potential for allergic rhinitis in a murine model via regulatory effects on IL-4, IL-10 and IL-13.Int Immunopharmacol. 2019 May;70:216-224.  ICF ;  Mouse.  
[IF=2.976] Peng?Y et al. Sonodynamic therapy improves anti?tumor immune effect by increasing the infiltration of CD8+ T cells and altering tumor blood vessels in murine B16F10 melanoma xenograft. Oncol Rep.?2018 Oct;40(4):2163-2170.?  WB ;  Mouse.  
[IF=2.76] da Silva Junior, Evaldo Moreira, et al. "Modulating effect of low intensity pulsed ultrasound on the phenotype of inflammatory cells." Biomedicine & Pharmacotherapy (2017).  IHC-P ;  Rat.  
[IF=2.744] Maria Apriliani Gani. et al. Bovine hydroxyapatite-based scaffold accelerated the inflammatory phase and bone growth in rats with bone defect. J APPL BIOMATER FUNC. ;():  IHC ;  Rat.  
[IF=2.674] Leiblein M et al. Size matters: Effect of granule size of the bone graft substitute (Herafill?) on bone healing using Masquelet's induced membrane in a critical size defect model in the rat's femur. J Biomed Mater Res B Appl Biomater. 2019 Nov 13.  IHC-P ;  Rat.  
[IF=2.485] Ju et al. An effective cytokine adjuvant vaccine induces autologous T-cell response against colon cancer in an animal model. (2016) BMC.Immunol. 17:31  IHC ;  Mouse.  
[IF=2.46] Wang, Shan, et al. "5-Aminolevulinic Acid–mediated Sonodynamic Therapy Reverses Macrophage and Dendritic Cell Passivity in Murine Melanoma Xenografts." Ultrasound in Medicine & Biology (2014).  IHC-P ;  Mouse.  
[IF=1.58] Liang, Zhuoping, et al. "Role of dendritic cells in consistency between upper and lower airway inflammatory responses: animal experimental studies." Int J Clin Exp Pathol 9.10 (2016): 10093-10104.  IHC-P ;  Rat.  
[IF=1.55] Chen, Quan, et al. "Prevention of ultraviolet radiation?induced immunosuppression by sunscreen in Candida albicans?induced delayed?type hypersensitivity." Molecular Medicine Reports (2016).  WB ;  Mouse.  
研究領域 腫瘤  干細胞  b-淋巴細胞  
抗體來源 Rabbit
克隆類型 Polyclonal
克 隆 號
交叉反應 Human,Mouse,Rat
產品應用 WB=1:500-2000,Flow-Cyt=2μg/Test
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
理論分子量 30 kDa
檢測分子量 60-65
細胞定位 細胞膜 
性    狀 Liquid
濃    度 1mg/ml
免 疫 原 KLH conjugated synthetic peptide derived from rat CD80: 251-321/321 <Cytoplasmic>
亞    型 IgG
純化方法 affinity purified by Protein A
緩 沖 液 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
保存條件 Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles.
注意事項 This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
PubMed PubMed
產品介紹 CD80 is a member of the Ig superfamily and serves as the ligand for two T cell molecules, CD28 and CTLA4. Interactions between CD28 and CD80 on activated B cells result in enhanced T cell activation. CD80 is rapidly induced on the surface of in vitro activated B cells, Epstein Barr Virus (EBV) transformed B cell lines, Burkitts lymphoma cell lines, freshly isolated follicular B lymphoma cells, T cells, and monocytes. It is also expressed at high levels in dendritic cells. It reacts weakly with a small proportion of non activated normal B cells and with HTLV1 infected T cells. CD80 does not react with peripheral monocytes, resting and activated normal T cells, T cell lines and T cell clones, nor with myelomonocytic cell lines.

Function:
Involved in the costimulatory signal essential for T lymphocytes activation. T-cell proliferation and cytokine production is induced by the binding of CD28 or CTLA-4 to this receptor.

Subcellular Location:
Membrane; Single-pass type I membrane protein.

Tissue Specificity:
Expressed on activated B-cells, macrophages and dendritic cells.

Similarity:
Contains 1 Ig-like C2-type (immunoglobulin-like) domain.
Contains 1 Ig-like V-type (immunoglobulin-like) domain.

Database links:


Entrez Gene: 941 Human

Entrez Gene: 12519 Mouse

Omim: 112203 Human

SwissProt: P33681 Human

SwissProt: Q00609 Mouse

Unigene: 838 Human

Unigene: 89474 Mouse




產品圖片
Sample: Lane 1: Raw264.7 (Mouse) Cell Lysate at 30 ug Lane 2: SP2/0 (Mouse) Cell Lysate at 30 ug Lane 3: Thymus (Rat) Lysate at 40 ug Lane 4: Raji (Human) Cell Lysate at 30 ug Lane 5: K562 (Human) Cell Lysate at 30 ug Primary: Anti-CD80 (bs-2211R) at 1/1000 dilution Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution Predicted band size: 30 kD Observed band size: 60 kD
Blank control: U937(blue). Primary Antibody: Rabbit Anti-CD80 antibody(bs-2211R), Dilution: 1μg in 100 μL 1X PBS containing 0.5% BSA; Isotype Control Antibody: Rabbit IgG (orange) ,used under the same conditions. Secondary Antibody: Goat anti-rabbit IgG-PE(white blue), Dilution: 1:200 in 1 X PBS containing 0.5% BSA. Protocol The cells were fixed with 2% paraformaldehyde (10 min).Primary antibody (bs-2211R, 1μg /1x10^6 cells) were incubated for 30 min on the ice, followed by 1 X PBS containing 0.5% BSA + 10% goat serum (15 min) to block non-specific protein-protein interactions. Then the Goat Anti-rabbit IgG/PE antibody was added into the blocking buffer mentioned above to react with the primary antibody at 1/200 dilution for 30 min on ice. Acquisition of 20,000 events was performed.
Blank control:Raji. Primary Antibody (green line): Rabbit Anti-CD80 antibody (bs-2211R) Dilution: 2ug/Test; Secondary Antibody : Goat anti-rabbit IgG-AF488 Dilution: 0.5ug/Test. Protocol The cells were incubated in 5%BSA to block non-specific protein-protein interactions for 30 min at room temperature .Cells stained with Primary Antibody for 30 min at room temperature. The secondary antibody used for 40 min at room temperature. Acquisition of 20,000 events was performed.
版權所有 2004-2026 www.www.ssxsbs.com 北京博奧森生物技術有限公司
通過國際質量管理體系ISO 9001:2015 GB/T 19001-2016    證書編號: 00124Q34771R2M/1100
通過國際醫療器械-質量管理體系ISO 13485:2016 GB/T 42061-2022    證書編號: CQC24QY10047R0M/1100
京ICP備05066980號-1         京公網安備110107000727號